Breast cancer patients globally may soon access a revolutionary new treatment option, developed by a surgical team based in southern China, that eliminates the need for secondary follow-up operations and leaves no visible scarring on the breast — addressing two of the most distressing drawbacks of conventional breast cancer care.
The innovative procedure was created by Liao Ning, lead of the breast surgery department at Guangdong Provincial People’s Hospital, and integrates three cutting-edge medical tools into one streamlined workflow: real-time ultrasound imaging, a fluorescent contrast dye that clearly demarcates tumor tissue from healthy breast cells, and a high-precision robotic surgical system. Peer-reviewed findings from the team’s clinical trials were recently published online in the *European Journal of Surgical Oncology*, marking international recognition of the technique’s safety and efficacy.
In standard breast-conserving surgery, between 10% and 15% of patients require a second procedure to remove residual cancerous tissue that is not detected or excised during the initial operation. Early clinical results for the new Chinese method show a 98.4% rate of complete tumor removal with clear, cancer-free margins, and no patients in the trial cohort required a follow-up surgery to address leftover malignant tissue.
The procedure demands close coordination among the surgical team: after the fluorescent dye is injected directly into the tumor under ultrasound guidance, the team has just five minutes to excise the highlighted tissue before the dye loses its visibility. The robotic system’s high-definition camera translates the invisible tumor boundary into a clear green visualization on the operating screen, while the device’s articulated mechanical arms perform excisions with precision between one and two millimeters — an accuracy that far outperforms manual surgical techniques.
Artificial intelligence also contributes to the procedure’s success before the first incision is made. AI algorithms process pre-operative scans and patient clinical data to construct a detailed 3D model of the tumor, map exact safe cutting margins, and generate a prediction of the breast’s final appearance after resection. This allows surgeons to plan both tumor removal and breast reshaping well in advance, reducing the risk of intra-operative error and suboptimal cosmetic outcomes.
Unlike conventional procedures that require incisions on the breast surface, all tumor removal work for the new method is done through a single small incision hidden in the armpit, leaving the outer breast completely free of visible scarring. For patients who previously faced an agonizing trade-off between cancer survival and preserving their body image and personal dignity, this breakthrough addresses both physical and psychological harms associated with traditional breast cancer treatment.